Although inherited systemic apoA-II amyloidosis is considered to be a rare disorder in humans, researchers consider that this illness is misdiagnosed [137] since it is confused with the acquired monoclonal immunoglobulin light-chain amyloidosis, and in this case, the illness is not properly treated. This evidence concerns the gene APOA2 and amyloidosis.